RECOMBINATE 1000 IU

Country: Israel

Bahasa: Inggeris

Sumber: Ministry of Health

Bahan aktif:

COAGULATION FACTOR VIII RECOMBINANT 1000 IU/VIAL

Boleh didapati daripada:

TEVA MEDICAL MARKETING LTD.

Kod ATC:

B02BD02

Borang farmaseutikal:

POWDER FOR SOLUTION FOR INJECTION

Laluan pentadbiran:

I.V

Dikeluarkan oleh:

BAXTER S.A., BELGIUM

Kumpulan terapeutik:

COAGULATION FACTOR VIII

Tanda-tanda terapeutik:

The use of Recombinate is indicated in the treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency). Recombinate is also indicated in the perioperative management of patients with haemophilia A. Recombinate is appropriate for use in children of all ages including the newborn. (Safety and efficacy studies have been performed in both previously treated and previously untreated children). The product in not suitable for the treatment of von Willebrand's disease.

Tarikh kebenaran:

2010-07-01